Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-06 · accession 0001048477-25-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-07 | 2025-03-06 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | S - Sale | $71.28 | -7,034 | 87.7K | -7% | -$501.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-06 | S | D | 7,034 | $71.28 | 87,655 | D | — | — | (F1) The price in column 4 is the weighted average price. The price actually received ranged from $71.276 to $71.285. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |